Evidence map›Paper›PMID 9199344›Full record

ArticleMolecular and cellular biology1997

Shc contains two Grb2 binding sites needed for efficient formation of complexes with SOS in B lymphocytes.

S L Harmer, A L DeFranco

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
9.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 93 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Article
  7. Structural and energetic aspects of Grb2-SH2 domain-swapping.Archives of biochemistry and biophysics · 2007
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Negative signaling in health and disease.Immunologic research · 1999
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

S L HarmerG.W. Hooper Foundation and Department of Biochemistry and Biophysics, University of California, San Francisco 94143-0552, USA.
A L DeFranco
San Francisco Foundation · US

Funding

REGULATION OF B LYMPHOCYTE PROLIFERATION BY ANTIGENR37AI020038 · NIAID · UNIVERSITY OF CALIFORNIA SAN FRANCISCO · PI DEFRANCO, ANTHONY L. · 1995 to 2004
$2.0M
REGULATION OF B-LYMPHOCYTE PROLIFERATION BY ANTIGENR01AI020038 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEFRANCO, ANTHONY L · 1985 to 2010
$1.8M
Regulation of B lymphocyte proliferation by antigenR56AI020038 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI DEFRANCO, ANTHONY L · 2013 to 2013
$363k
NIAID NIH HHS AI20038
6 · The paper itself

Abstract

Cross-linking of the B-cell antigen receptor (BCR) induces tyrosine phosphorylation of Shc, which is believed to lead to the activation of Ras. Previous work has shown that tyrosine-phosphorylated Shc forms complexes with another adapter protein, Grb2, and the Ras guanine nucleotide exchange factor SOS. Here, we demonstrate that phosphorylation of Shc by the hematopoietic cell-specific tyrosine kinase Syk induces binding of Grb2 to Shc, suggesting that Syk phosphorylates Shc in stimulated B cells. Surprisingly, Syk-phosphorylated Shc possesses two Grb2 binding sites rather than the one site that has been previously reported. Both of these sites are required for efficient formation of Shc-Grb2-SOS complexes in vitro and in vivo. We suggest that two Grb2 proteins anchored by a single Shc protein bind simultaneously to one SOS molecule, resulting in a complex that is more stable than a complex containing only a single Grb2 protein bound to one SOS molecule. This model is consistent with our observation that BCR stimulation greatly increases the amount of SOS associated with Grb2.

Indexed as

Adaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportAmino Acid SequenceAnimalsBinding SitesB-LymphocytesCells, CulturedEnzyme PrecursorsGRB2 Adaptor ProteinGTP-Binding ProteinsHumansIntracellular Signaling Peptides and ProteinsMacromolecular SubstancesMembrane ProteinsMicePhosphotyrosineAdaptor Proteins, Signal TransducingAdaptor Proteins, Vesicular TransportEnzyme PrecursorsGRB2 Adaptor ProteinGRB2 protein, humanGrb2 protein, mouseGTP-Binding ProteinsIntracellular Signaling Peptides and ProteinsMacromolecular SubstancesMembrane ProteinsPhosphotyrosineProteinsProtein-Tyrosine KinasesReceptors, Antigen, B-CellSHC1 protein, humanShc1 protein, mouseShc Signaling Adaptor ProteinsSon of Sevenless ProteinsSrc Homology 2 Domain-Containing, Transforming Protein 1Syk KinaseSYK protein, humanSyk protein, mouse

Identifiers

PMID9199344
PMCPMC232262
OpenAlexW2132952690

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.